Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Features include always present findings: Paraganglioma. 3 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Lab test results | 1 | Elevated circulating catecholamine level |
Heart and blood vessels |
SLC25A11 function has not been fully characterized.
Pheochromocytoma/paraganglioma syndrome 6 is associated with mutations in the SLC25A11 gene on chromosome 17.
Genetic testing for SLC25A11 is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for pheochromocytoma/paraganglioma syndrome 6 has been reported in the published literature.
Phenotype severity distribution: 1 always present feature.
No clinical trials have been registered for pheochromocytoma/paraganglioma syndrome 6.
124 publications have been identified in PubMed for pheochromocytoma/paraganglioma syndrome 6. Research spans Review / Meta-Analysis (30%), Epidemiology / Natural History (19%), and Case Report / Case Series (16%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 37 | 30% |
Data assembled from 5 of 12 sources · Last updated Sep 20, 2026, 5:38 PM UTC
Online Mendelian Inheritance in Man
Genetic and Rare Diseases Info Center
1
Hypertension |
Age of onset: adulthood.
Disease patterns and progression
24 |
19% |
Patient case studies | 20 | 16% |
Clinical study results | 18 | 15% |
Laboratory research | 15 | 12% |
Testing and diagnosis research | 8 | 6% |
Other research | 1 | 1% |
New treatment approaches | 1 | 1% |
Zhang B (2026). [PMID: 41469155](https://pubmed.ncbi.nlm.nih.gov/41469155/). *J Nucl Med*. [Diagnostic / Biomarker]
Cole Y (2026). [PMID: 41518596](https://pubmed.ncbi.nlm.nih.gov/41518596/). *J Clin Endocrinol Metab*. [Case Report / Case Series]
Qi W (2026). [PMID: 41331528](https://pubmed.ncbi.nlm.nih.gov/41331528/). *Surg Endosc*. [Diagnostic / Biomarker]
Zawadzka K (2026). [PMID: 40578302](https://pubmed.ncbi.nlm.nih.gov/40578302/). *J Clin Endocrinol Metab*. [Case Report / Case Series]
Svendsen LK (2026). [PMID: 41183483](https://pubmed.ncbi.nlm.nih.gov/41183483/). *J Clin Endocrinol Metab*. [Review / Meta-Analysis]
Tong JY (2026). [PMID: 42205419](https://pubmed.ncbi.nlm.nih.gov/42205419/). *World J Otorhinolaryngol Head Neck Surg*. [Review / Meta-Analysis]
Bozzani A (2026). [PMID: 41671602](https://pubmed.ncbi.nlm.nih.gov/41671602/). *J Surg Res*. [Case Report / Case Series]
Liu J (2026). [PMID: 41994490](https://pubmed.ncbi.nlm.nih.gov/41994490/). *J Endocr Soc*. [Epidemiology / Natural History]
Charbel C (2026). [PMID: 41284030](https://pubmed.ncbi.nlm.nih.gov/41284030/). *Abdom Radiol (NY)*. [Review / Meta-Analysis]
Fischer A (2026). [PMID: 41394112](https://pubmed.ncbi.nlm.nih.gov/41394112/). *J Endocr Soc*. [Epidemiology / Natural History]